David DeMartino Appointed as Senior Vice President at Zimmer Biomet
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a prominent name in global medical technology, has announced the appointment of David DeMartino as the new Senior Vice President of Investor Relations. He will report directly to Ivan Tornos, the President and CEO, and is expected to start his new role soon.
Enhancing the Investor Relations Strategy
In this critical position, Mr. DeMartino will play a key role in shaping and advancing Zimmer Biomet's investor relations strategy. His responsibilities will include fostering and maintaining strong relationships within the investment and financial sectors. Ivan Tornos expressed his excitement about DeMartino joining the team, highlighting his vast experience in healthcare and his impressive professional background.
Extensive Experience in the Healthcare Industry
With more than 25 years of diverse experience in the healthcare industry, DeMartino brings a wealth of expertise in asset management, equity research, and investment banking to Zimmer Biomet. Before taking on this new role, he was the Chief Strategy Officer at Nyxoah, a company focused on developing innovative solutions for Obstructive Sleep Apnea. Additionally, Mr. DeMartino has worked as a portfolio manager and has held senior analyst positions at several respected firms, including Citadel and Pura Vida Investments.
Career Path and Educational Background
DeMartino's professional journey is marked by a strong record in sell-side equity research and healthcare investment banking. He began his career at Deutsche Bank and holds a BA in Economics from Washington and Lee University. His varied experience across medical devices, biotechnology, and healthcare technologies uniquely positions him for success in his new role.
About Zimmer Biomet
Zimmer Biomet is well-known for its extensive medical technology portfolio, which aims to improve mobility and enhance health outcomes. The company is committed to transforming the patient experience through innovative products and integrated digital technologies, including advancements in artificial intelligence.
With a legacy that spans over 90 years, Zimmer Biomet is dedicated to providing high-quality solutions to healthcare providers and their patients while promoting a culture of continuous evolution and innovation in their practices.
Company Contact Information
Media Contact
Heather Zournas-Lubeski
(445) 248-0577
Investors Contact
Zach Weiner
(908) 591-6955
Frequently Asked Questions
Who is David DeMartino?
David DeMartino is the newly appointed Senior Vice President of Investor Relations at Zimmer Biomet, bringing a wealth of experience in healthcare and finance to the role.
What will DeMartino's responsibilities include?
His main focus will be on developing the investor relations strategy and strengthening connections with the investment community.
What is Zimmer Biomet recognized for?
Zimmer Biomet specializes in cutting-edge medical technologies designed to enhance mobility and improve health outcomes for patients worldwide.
How long has Zimmer Biomet been in business?
The company has been a key player in the medical technology industry for over 90 years.
Where can I find more information about Zimmer Biomet?
For further details, you can visit Zimmer Biomet's official website or check their updates on various social media platforms.
